Illness	Number of cases
Pyothorax without fistula (J86.9)	67
Pleural effusion not elsewhere classified (J90)	50
Malignant neoplasm of bronchus and lung (C34.3)	49
Malignant neoplasm of bronchus and lung (C34.1)	48
Secondary malignant neoplasm of respiratory and digestive organs (C78.0)	44
Secondary malignant neoplasm of respiratory and digestive organs - Secondary malignant neoplasm of pleura (C78.2)	44
3 Pneumothorax (J93.1)	24
Other respiratory disorders - Other disorders of lung (J98.4)	14
Injury of other and unspecified intrathoracic organs (S27.1)	11
3 Pneumothorax (J93.8)	10

Top 10 treatments

Treatment	Number
Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930)	247
Measurement of lung function in an airtight cabin - whole body plethysmography (1-710)	215
Examination of the trachea and the bronchi by endoscopy (1-620.00)	210
Anaesthesia with administration of an anaesthetic into a vein (8-900)	193
Examination of the bronchi by taking a sample of fluid or tissue with a needle (1-843)	169
Analysis of the amount of carbon monoxide taken in and given off by the lungs (1-711)	148
(1-620.30)	146
Treatment on the intensive care unit (basic procedures) (8-980.0)	101
(5-98c.1)	88
Computed tomography (CT) of the chest without contrast medium (3-202)	69

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2000

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	0
Bezeichnung
Teilnahme externe Qualitätssicherung	0
Bezeichnung
Teilnahme externe Qualitätssicherung	2

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ27

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
34	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
34	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
34	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Student training (clinical traineeship / internship year)	Famulaturen: 6 PJ: 1
Participation in multi-centre Phase I/II studies	- CRISP-Register: NIS (Nicht interventionelle Studie): - FINN-Studie: NIS - NENI: NIS - SPACE-Studie: Einarmige Phase II Studie - SAFFRON Studie: Phase III; NSCLC - TIGER Meso: NIS Register: - Klinisches Register für schweres Asthma - Mukoviszidose Register - OHONIV_OCONIV